Kinematic characterization of functional reach to grasp in normal and in motor disabled children

The upper limb kinematics were assessed during the execution of a functional task in healthy adults, children and in children with motor disabilities (i.e. hemiplegic cerebral palsy (HCP) and movement disorders (MD)). The quantitative assessment was performed considering the time durations, the amplitude of movements at different joints and the periodicity of the acceleration patterns.

Compared to adults, healthy children showed increased motion amplitudes both at the head and at the trunk; this is suggestive of a reduced ability to stabilize the head during reaching. Furthermore, healthy children showed a reduced periodicity of the acceleration patterns which is interpreted as an indication of the on-going maturation process of the central nervous system.

Subjects with HCP and MD showed increased movement duration; however this general finding does not account for specific differences. Indeed, children with HCP showed reduced range of motion (ROM) of the shoulder on the frontal plane which is counterbalanced by the introduction of compensatory movements of the trunk. Conversely, in children with MD, the ROM is well-preserved whereas the movements of the head are increased especially at higher speed. Finally, the periodicity of the end-effect is dramatically reduced both in HCP and MD. This suggests the existence of out-of-phase corrective strokes that may indicate an increased variability of the motor control commands.

The results of this study reinforce the evidence that kinematic analysis may add valuable information to understand the developmental process in healthy children and to differentiate distinct levels of impairment in children with neurological disorders.     

Neurofibromatosis 1 and massive hemothorax: a fatal combination

Type 1 neurofibromatosis (NF 1), a rare genetic disease with autosomal dominant transmission, has typical dermatologic manifestations with pathognomonic Lisch nodules, and is rarely known for vascular alterations. Among these, aneurysmal dilatation is the most common form. We report a fatal case of massive hemothorax due to a spontaneous rupture of the left pulmonary artery branch micro-aneurysm in a NF 1 patient. Indeed, spontaneous rupture of these pathologic vessels is very rare in clinical practice and the literature, but, for its potentially life-threatening complications, there is the need for it to be taken into account in differential diagnosis. The origin of bleeding was first confirmed by computed tomography angiography (CTA). The patient’s condition worsened suddenly leading to pulmonary hemorrhage and death. A clinical autopsy was required to assess the definitive cause of death.     

Globe artichoke as a functional food

Globe artichoke (Cynara cardunculus var. scolymus L. Fiori) is a traditional component of the Mediterranean diet. Artichoke edible parts are one of the richest dietary sources of polyphenols with high bioavailability, and contain also high-quality inulin, fibres and minerals. Moreover, pharmaceutical artichoke leaf extracts show hypocholesterolemic and choleretic properties. Several clinical studies have shown that the bioactive properties of globe artichoke are due to the high content of polyphenolic compounds in flower heads and leaves, in particular hydroxycinnamates and flavonoids. The total antioxidant capacity of artichoke flower heads is one of the highest reported for vegetables, and is strictly related to their polyphenolic content. Different agronomic variables, such as mycorrhizal inoculation, may affect plant secondary metabolism, and in particular the production of metabolites with health-promoting activities. Our recent data showed large increases of total phenolic content and antioxidant activity in leaves and flower heads of mycorrhizal artichoke plants.     

Improved analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with diode array detection for determination of cellular dihydropyrimidine dehydrogenase activity and pharmacokinetic profiling

Administration of 5-fluorouracil (5-FU) may be associated with severe toxicities in patients who are deficient of dihydropyrimidine dehydrogenase (DPD) activity. For this reason, a sensitive HPLC method for the analysis of 5-FU and 5-fluoro-5,6-dihydrouracil (5-FDHU) was developed in the present study for the determination of DPD activity in nucleated cells of peripheral blood and pharmacokinetic analysis of 5-FU and 5-FDHU in humans. 5-FU and 5-FDHU were extracted from biologic matrices by adding sodium acetate, sodium sulfate, and diethyl ether/propanol. Dried samples were reconstituted in a mobile phase (KH2PO4 35 mmol/L, pH 4.0), isocratically eluted with a Hypersil C18 stationary phase (25 cm x 4.6 mm, 10 microm), and detected by a diode array detector (measurement and reference wavelengths, 215 and 360 nm, respectively). 5-Fluorocytosine (internal standard), 5-FDHU, and 5-FU were eluted within 13 minutes of the injection without interferences. Recoveries ranged between 81% to 85% for all compounds, and the method proved to be linear, with a coefficient of linearity of 0.999. The limits of detection and quantification were 3.2 and 16 ng/mL, respectively, and the within-day and between-day CV were less than 10% for both 5-FU and 5-FDHU. The present assay proved to be sufficiently sensitive and specific to evaluate cellular DPD activity and measure 5-FU and 5-FDHU plasma concentrations in cancer patients, thus allowing therapeutic 5-FU monitoring in patients and identification of DPD-deficient subjects at major risk of severe toxicities.